Guided Therapeutics signs $19.4M license agreement with Turkish partner ITEM

Guided Therapeutics signed a multiyear license agreement with Turkish distribution partner ITEM for the manufacture of patented single-patient-use Cervical Guides in Turkey. The agreement includes fees totaling $1.1 million in 2018 and expected minimum revenues of approximately $19.4 million over twelve years.

“This watershed agreement has the potential to help redefine cervical cancer screening in the 21st century by applying brand new technology to a pervasive and largely unmet need in most countries.”biospace.com

• 1 source
• biospace.comGuided Therapeutics Completes License Agreement with Turkish Distribution Partner with Ministry of Health Backing - BioSpaceAnnalee ArmstrongApr 2, 2018

Summarized from public sources; check the original articles before acting on it.